Form 8-K - Current report:
SEC Accession No. 0001104659-26-083559
Filing Date
2026-07-14
Accepted
2026-07-14 17:06:03
Documents
11
Period of Report
2026-07-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K capr-20260709x8k.htm   iXBRL 8-K 36988
  Complete submission text file 0001104659-26-083559.txt   145102

Data Files

Seq Description Document Type Size
2 EX-101.SCH capr-20260709.xsd EX-101.SCH 2667
3 EX-101.LAB capr-20260709_lab.xml EX-101.LAB 15263
4 EX-101.PRE capr-20260709_pre.xml EX-101.PRE 9651
14 EXTRACTED XBRL INSTANCE DOCUMENT capr-20260709x8k_htm.xml XML 4636
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 261174937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)